Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/03/2026 ,inter alia, to consider and approve issue of bonus ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biogen Pharmachem Industries Ltd has informed BSE that its Board of Directors will meet on Monday, 23rd March 2026 at the registered office in Rajkot. The key agenda is to consider and approve the issue of bonus shares to shareholders, subject to applicable provisions and shareholder approval. The company has a CIN of L51100GJ1995PLC026702 and trades on BSE under scrip code 531752. The intimation is made under Regulation 29 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.
If approved, bonus shares will increase the total share count and may improve liquidity, but the exact ratio is not yet disclosed. Shareholders should wait for the board's decision on 23rd March 2026 and subsequent shareholder approval before assessing the impact on their holdings.